Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/221900
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Peyman, Mona | - |
dc.contributor.author | Babin-Ebell, Anna | - |
dc.contributor.author | Rodríguez-Rodríguez, Rosalía | - |
dc.contributor.author | Rigon, Matilde | - |
dc.contributor.author | Aguilar-Recarte, David | - |
dc.contributor.author | Villarroya i Terrade, Joan | - |
dc.contributor.author | Planavila Porta, Ana | - |
dc.contributor.author | Villarroya i Gombau, Francesc | - |
dc.contributor.author | Palomer Tarridas, Francesc Xavier | - |
dc.contributor.author | Barroso Fernández, Emma | - |
dc.contributor.author | Vázquez Carrera, Manuel | - |
dc.date.accessioned | 2025-06-30T08:31:21Z | - |
dc.date.available | 2025-06-30T08:31:21Z | - |
dc.date.issued | 2024-12-01 | - |
dc.identifier.issn | 1478-811X | - |
dc.identifier.uri | https://hdl.handle.net/2445/221900 | - |
dc.description.abstract | Background Endoplasmic reticulum (ER) stress-mediated increases in the hepatic levels of the very low-density lipoprotein (VLDL) receptor (VLDLR) promote hepatic steatosis by increasing the delivery of triglyceride-rich lipoproteins to the liver. Here, we examined whether the NAD(+)-dependent deacetylase sirtuin 1 (SIRT1) regulates hepatic lipid accumulation by modulating VLDLR levels and the subsequent uptake of triglyceride-rich lipoproteins. Methods Rats fed with fructose in drinking water, Sirt1−/− mice, mice treated with the ER stressor tunicamycin with or without a SIRT1 activator, and human Huh-7 hepatoma cells transfected with siRNA or exposed to tunicamycin or different inhibitors were used. Results Hepatic SIRT1 protein levels were reduced, while those of VLDLR were upregulated in the rat model of metabolic dysfunction-associated steatotic liver disease (MASLD) induced by fructose-drinking water. Moreover, Sirt1−/− mice displayed increased hepatic VLDLR levels that were not associated with ER stress, but were accompanied by an increased expression of hypoxia-inducible factor 1α (HIF-1α)-target genes. The pharmacological inhibition or gene knockdown of SIRT1 upregulated VLDLR protein levels in the human Huh-7 hepatoma cell line, with this increase abolished by the pharmacological inhibition of HIF-1α. Finally, SIRT1 activation prevented the increase in hepatic VLDLR protein levels in mice treated with the ER stressor tunicamycin. Conclusions Overall, these findings suggest that SIRT1 attenuates fatty liver development by modulating hepatic VLDLR levels. | - |
dc.format.extent | 11 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | BioMed Central | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1186/s12964-024-01666-y | - |
dc.relation.ispartof | Cell Communication and Signaling, 2024, vol. 22, p. 297 | - |
dc.relation.uri | https://doi.org/10.1186/s12964-024-01666-y | - |
dc.rights | cc-by (c) Peyman, M. et al., 2024 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) | - |
dc.subject.classification | Malalties del fetge | - |
dc.subject.classification | Trastorns del metabolisme dels lípids | - |
dc.subject.other | Liver diseases | - |
dc.subject.other | Lipid metabolism disorders | - |
dc.title | SIRT1 regulates hepatic vldlr levels | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 749161 | - |
dc.date.updated | 2025-06-30T08:31:21Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
862369.pdf | 1.92 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License